Zhengye Biotechnology Holding (ZYBT) Finished Goods (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Finished Goods for 3 consecutive years, with $1.9 million the latest figure, recorded in Q4 2025.

• Quarterly Finished Goods fell 22.68% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (down 22.68% YoY) and the FY2025 annual result came in at $1.9 million, down 20.29% from the prior year.
• Finished Goods eased to $1.9 million in Q4 2025 per ZYBT's latest filing, from $2.5 million in the prior quarter.
• Over the last five years, Finished Goods for ZYBT reached as high as $2.5 million in Q4 2024 and fell as low as $1.9 million in Q4 2025.
• A 3-year average of $2.1 million and a median of $2.1 million in 2023 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2024 — Finished Goods climbed 19.65% — and 2025, when it fell 22.68%.
• Year by year, Finished Goods stood at $2.1 million in 2023, then increased by 19.65% to $2.5 million in 2024, then fell by 22.68% to $1.9 million in 2025.
• According to Business Quant data, Finished Goods over the past three periods registered $1.9 million, $2.5 million, and $2.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.